Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 4 sources · 10 days · First seen · Last updated
Breast cancer screening and survival trends
Overview
Recent medical research and data highlight evolving perspectives on breast cancer screening and survival. An analysis of eight major randomized mammography trials suggests that the rate of breast cancer overdiagnosis—where slow-growing cancers are detected that would not have caused harm—may be below 5%, which is significantly lower than previous estimates of 30% to 50%.
Concurrently, medical experts report substantial improvements in patient outcomes. Five-year survival rates have risen from approximately 70% in the 1970s to over 95% today, a trend largely attributed to early detection. Data from the National Cancer Institute indicates that for cases where the cancer is confined to the breast, the five-year relative survival rate is 100%. While mammography remains the standard for screening, professionals note that modern molecular testing is increasingly used to tailor treatments and help some patients avoid chemotherapy.
Entities
Sisse Helle Njor · Dr. Alberto Montero · University of Southern Denmark · Case Western Reserve University School of Medicine · JNCI: Journal of the National Cancer Institute
Timeline
-
[HEALTH] 2 sourcesBreast cancer survival rates reach over 95% through early detection
Breast cancer five-year survival rates have risen to over 95% due to early detection and improved treatments, with doctors emphasizing mammography as the gold standard for average-risk women.
-
[HEALTH] 2 sourcesBreast cancer overdiagnosis may be below 5%, study finds
A reanalysis of major mammography trials suggests breast cancer overdiagnosis may be below 5%, challenging previous estimates of 30% to 50%.
Sources
hcnews.com · pontevedrarecorder.com · scitechdaily.com · time.news